Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association

Related Experiment Video

Updated: Jul 14, 2026

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
06:08

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions

Published on: March 8, 2019

Paul E Norman1, Timothy M E Davis, Max Tan Quoc Le

  • 1School of Surgery and Pathology, University of Western Australia, Fremantle, Western Australia. pnorman@cyllene.uwa.edu

Connective Tissue Research
|May 25, 2007
PubMed

Insights

Diabetes and abdominal aortic aneurysm (AAA) show a surprising inverse relationship. This review explores how matrix biology in diabetes may protect against AAA development, offering therapeutic insights.

Area of Science:

  • Vascular Biology
  • Metabolic Diseases
  • Atherosclerosis Research

Background:

  • Case-control studies reveal a negative association between diabetes and abdominal aortic aneurysm (AAA).
  • This interaction is under-researched despite its potential to elucidate disease mechanisms.
  • Aneurysmal aortas exhibit inflammation and matrix degradation, contrasting with diabetes' matrix synthesis and resistance to proteolysis.

Purpose of the Study:

  • To compare matrix biology changes in diabetes and AAA.
  • To explore molecular mechanisms underlying the negative association.
  • To identify potential therapeutic implications for both conditions.

Main Methods:

  • Minireview comparing matrix biology in diabetes and AAA.
  • Exploration of molecular mechanisms through literature synthesis.
  • Analysis of advanced glycation end products' role in vascular matrix.

Main Results:

  • Diabetes involves increased matrix synthesis and reduced degradation, unlike AAA's matrix loss.
  • Advanced glycation end products in diabetes enhance vascular matrix resistance to proteolysis.
  • Contrasting matrix remodeling pathways in diabetes and AAA suggest protective effects.

Conclusions:

  • The matrix biology differences between diabetes and AAA may explain their inverse relationship.
  • Understanding these mechanisms could lead to novel therapeutic strategies.
  • Further research into diabetes-induced vascular protection against AAA is warranted.

More Related Videos

A Calcium Phosphate-Induced Mouse Abdominal Aortic Aneurysm Model05:14

A Calcium Phosphate-Induced Mouse Abdominal Aortic Aneurysm Model

Published on: November 18, 2022

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...